Ticker Details
Immunovant, Inc.
IPO Date:	June 7, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.41B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 2.74%
Avg Daily Range (30 D):	$0.48 | 1.83%
Avg Daily Range (90 D):	$0.54 | 2.28%

Institutional Daily Volume
Avg Daily Volume:	.88M
Avg Daily Volume (30 D):	1.15M
Avg Daily Volume (90 D):	1.38M

Trade Size
Avg Trade Size (Sh.):	77
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	3,094
Avg Institutional Trade:	$2.3M
Avg Institutional Trade (30 D):	$2.57M
Avg Institutional Trade (90 D):	$2.87M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.68M
Avg Closing Trade (30 D):	$4.87M
Avg Closing Trade (90 D):	$5.96M
Avg Closing Volume:	164.28K

News

Feb 6, 2026 @ 12:00 PM Immunovant Provides Corporate Updates and Reports ... Source: Immunovant, Inc.

Dec 18, 2025 @ 7:35 AM Is Immunovant Stock a Buy After Roivant Sciences I... Source: Robert Izquierdo

Sep 17, 2025 @ 9:49 PM CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER... Source: Kahn Swick & Foti, Llc

Sep 3, 2025 @ 10:17 PM Why Immunovant Stock Blasted Higher Today Source: Eric Volkman

Sep 3, 2025 @ 4:57 PM Immunovant Unveils Durability and Treatment-Free S... Source: Immunovant, Inc.

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-2.68	$-.61	$-.73
Diluted EPS	$-2.68	$-.61	$-.73
Revenue
Gross Profit
Net Income / Loss	$-464.2M	$-110.64M	$-126.5M
Operating Income / Loss
Cost of Revenue
Net Cash Flow	$338.6M	$-.38M	$-.88M
PE Ratio